Skip to content
The Kids Research Institute Australia logo
Donate

No results yet

Search

News & Events

Ten Day Continuous Glucose Monitoring study – now recruiting

The Children’s Diabetes Centre is now recruiting for a new continuous glucose monitoring study.

News & Events

Camp volunteers needed

Diabetes WA is looking for volunteers to take part in the PMH and Diabetes WA Camp for 9 and 10 year olds in Hillarys in September.

News & Events

Farewell Tarini

After nearly two-and-a-half years in sunny Perth, Dr Tarini Chetty is headed back home to Scotland. Before she departs our shores.

News & Events

ENDIA milestone

The ENDIA study — Australia’s largest study into the causes of Type 1 Diabetes— reached a significant milestone when it recruited its 700th patient in Perth.

Centre of Excellence

The Rio Tinto Children’s Diabetes Centre; a Breakthrough T1D Centre of Excellence at The Kids Research Institute Australia and Perth Children’s Hospital (PCH), is a global hub for research into type 1 diabetes (T1D) in children.

Resources

Find newsletters, guidelines, publications and videos in the one spot.

Sport Resources

People living with Type 1 diabetes (T1D) can participate in all forms of physical activity, but it can sometimes be a little more challenging.

Community of Practice

Our goal is to accelerate the dissemination and implementation of evidence-based models of care for children and young people living with Type 1 Diabetes.

News & Events

'Artificial pancreas' helps ease diabetes burden

The Centre is currently involved in an international effort to develop revolutionary closed- loop 'artificial pancreas' technology. It is also leading a multi-centre Australian trial of these portable devices at home in young people with diabetes.

Research

Clinical Outcomes with MiniMedTM 780G Advanced Hybrid Closed-Loop Therapy in 2- to 6-Year-Old Children with Type 1 Diabetes

Advanced hybrid closed-loop (AHCL) therapy with the Medtronic MiniMed™ 780G system improves glycemia; however, the clinical outcomes in younger children remain less established. This pilot study aimed to explore the continuous glucose monitoring (CGM) metrics in very young children on AHCL. Children between 2 and 7 years of age and on insulin pump therapy were recruited.